Picture of WELL Health Technologies logo

WELL — WELL Health Technologies News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Canada's WELL Health Q2 revenue rises, lifts 2026 outlook

Canada's WELL Health Q2 revenue rises, lifts 2026 outlook


Overview

  • Canada digital healthcare firm's Q2-2026 revenue rose 12% yr/yr, driven by Canadian Patient Services

  • Adjusted EBITDA fell 3% due to prior-year Circle Medical Deferrals impact

  • Company raised 2026 revenue and adjusted EBITDA guidance, completed two Canadian clinic acquisitions


Outlook

  • WELL raises 2026 revenue guidance to $1.58 bln-$1.65 bln from $1.55 bln-$1.65 bln

  • Company lifts 2026 Adjusted EBITDA guidance to $185 mln-$195 mln from $175 mln-$185 mln

  • WELL expects no further Circle Medical Deferral recognition for the remainder of 2026


Result Drivers

  • CANADIAN PATIENT SERVICES - Co said Q2-2026 revenue growth was driven by 32% increase in Canadian Patient Services revenue, attributed to higher patient visits and expanded provider base

  • CIRCLE MEDICAL DEFERRALS - Co said 3% decline in Adjusted EBITDA reflected impact of Circle Medical Deferrals which had boosted prior-year results

  • ACQUISITIONS - Co said two acquisitions during Q2-2026 expanded Canadian clinic network to 275 clinics and contributed to annualized Adjusted EBITDA run-rate exceeding $100 mln


Company press release: ID:nNFC8F6fsK


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Adjusted EPS

C$0.04

Q2 Adjusted Gross Margin

44.6%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for WELL Health Technologies Corp. is C$7.13, about 74.2% above its August 5 closing price of C$4.09

  • The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 14 three months ago


Reuters Recommended Reads

  • Aug 6 - Canada's Medical Facilities Corp Q2 net income falls

  • Aug 6 - Privia Health Q2 revenue beats estimates, outlook raised

  • Aug 6 - LifeStance Health Q2 revenue beats on higher visit volumes


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on WELL Health Technologies

See all news